Emergent BioSolutions (EBS) EPS (Basic) (2010 - 2026)
Emergent BioSolutions (EBS) recorded quarterly EPS (Basic) of $0.13 in Q1 2026, up 112.87% quarter-over-quarter from -$1.01 in Q4 2025, and down 89.6% on a YoY basis from $1.25 in Q1 2025.
Emergent BioSolutions (EBS) EPS (Basic) (2010 - 2026) Analysis & Trends
Emergent BioSolutions' EPS (Basic) history runs 17 years deep, the most recent figure standing at $0.13 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 89.6% year-over-year to $0.13; the TTM figure through Mar 2026 stood at -$0.14 (up 94.49% YoY), while the FY2025 annual figure was $0.98, up 127.22% from the prior year.
- EPS (Basic) was $0.13 for Q1 2026 at Emergent BioSolutions, up from -$1.01 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $2.16 in Q3 2024 to a low of -$5.38 in Q2 2024.
- Historically, EPS (Basic) has averaged -$1.27 across 5 years, with a median of -$0.88 in 2023.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) plunged 10500.0% in 2022, then surged 635.29% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$1.34 in 2022, then soared by 34.33% to -$0.88 in 2023, then jumped by 35.23% to -$0.57 in 2024, then plunged by 77.19% to -$1.01 in 2025, then surged by 112.87% to $0.13 in 2026.
- The last three EPS (Basic) figures came in at $0.13 (Q1 2026), -$1.01 (Q4 2025), and $0.96 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.32 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.32 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.97 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.83 |
| 10 | Emergent BioSolutions | 412.09 Mn | 250.59 Mn | 84.10 Mn | 0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | -1.01 |
| Sep 30, 2025 | 0.96 |
| Jun 30, 2025 | -0.22 |
| Mar 31, 2025 | 1.25 |
| Dec 31, 2024 | -0.57 |
| Sep 30, 2024 | 2.16 |
| Jun 30, 2024 | -5.38 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | -0.88 |
| Sep 30, 2023 | -5.08 |
| Jun 30, 2023 | -5.16 |
| Mar 31, 2023 | -3.71 |
| Dec 31, 2022 | -1.34 |
| Sep 30, 2022 | -1.75 |
| Jun 30, 2022 | -1.06 |
| Mar 31, 2022 | -0.09 |
| Dec 31, 2021 | 3.62 |
| Sep 30, 2021 | -0.75 |
| Jun 30, 2021 | -0.01 |